Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Neal

Showing results (51-60 of 302) with videos related to

Pageof 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancerJose L Dominguez-Escrig, John D Kelly, David E Neal, et al.
BMJ Open|May 17, 2014
Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysisTengbin Xiong, Rebecca M Turner, Yinghui Wei, et al.
The Journal of Cell Biology|July 20, 2005
Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptorsIan G Mills, Luke Gaughan, Craig Robson, et al.
The Cochrane Database of Systematic Reviews|February 17, 2012
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomyJune D Cody, Ghulam Nabi, Norman Dublin, et al.
Molecular Oncology|February 18, 2014
Regulation of the localisation and function of the oncogene LYRIC/AEG-1 by ubiquitination at K486 and K491Hayley J Luxton, Karin Barnouin, Gavin Kelly, et al.
BMC Urology|March 1, 2014
Key considerations for the experimental training and evaluation of cancer odour detection dogs: lessons learnt from a double-blind, controlled trial of prostate cancer detectionKevin R Elliker, Barbara A Sommerville, Donald M Broom, et al.
Statistical Methods in Medical Research|September 14, 2014
Misclassification of outcome in case-control studies: Methods for sensitivity analysisRebecca Gilbert, Richard M Martin, Jenny Donovan, et al.
International Journal of Cancer|October 2, 2012
Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT studyLuisa Zuccolo, Sarah J Lewis, Jenny L Donovan, et al.
The Prostate|April 19, 2007
Labeling and identification of LNCaP cell surface proteins: a pilot studyHayley C Whitaker, David P B Stanbury, Claire Brinham, et al.
The Journal of Urology|November 21, 2002
Transurethral prostate resection, noncontact laser therapy or conservative management in men with symptoms of benign prostatic enlargement? An economic evaluationSian M Noble, Joanna Coast, Sara Brookes, et al.
Pageof 31

Showing results (51-60 of 302) with videos related to

Sort By:
Pageof 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancerJose L Dominguez-Escrig, John D Kelly, David E Neal, et al.
BMJ Open|May 17, 2014
Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysisTengbin Xiong, Rebecca M Turner, Yinghui Wei, et al.
The Journal of Cell Biology|July 20, 2005
Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptorsIan G Mills, Luke Gaughan, Craig Robson, et al.
The Cochrane Database of Systematic Reviews|February 17, 2012
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomyJune D Cody, Ghulam Nabi, Norman Dublin, et al.
Molecular Oncology|February 18, 2014
Regulation of the localisation and function of the oncogene LYRIC/AEG-1 by ubiquitination at K486 and K491Hayley J Luxton, Karin Barnouin, Gavin Kelly, et al.
BMC Urology|March 1, 2014
Key considerations for the experimental training and evaluation of cancer odour detection dogs: lessons learnt from a double-blind, controlled trial of prostate cancer detectionKevin R Elliker, Barbara A Sommerville, Donald M Broom, et al.
Statistical Methods in Medical Research|September 14, 2014
Misclassification of outcome in case-control studies: Methods for sensitivity analysisRebecca Gilbert, Richard M Martin, Jenny Donovan, et al.
International Journal of Cancer|October 2, 2012
Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT studyLuisa Zuccolo, Sarah J Lewis, Jenny L Donovan, et al.
The Prostate|April 19, 2007
Labeling and identification of LNCaP cell surface proteins: a pilot studyHayley C Whitaker, David P B Stanbury, Claire Brinham, et al.
The Journal of Urology|November 21, 2002
Transurethral prostate resection, noncontact laser therapy or conservative management in men with symptoms of benign prostatic enlargement? An economic evaluationSian M Noble, Joanna Coast, Sara Brookes, et al.
Pageof 31